Keywords:
Tissue characterisation, Hyperplasia / Hypertrophy, Aneurysms, Contrast agent-intravenous, MR, Cardiac
Authors:
V. Palmisano, M. Mura, M. Porcu, L. Saba; Cagliari/IT
Purpose
Apical hypertrophic cardiomyopathy (ApHCM) represents a relatively uncommon phenotype of hypertrophic cardiomyopathy (HCM),
affecting mostly the apex of the left ventricle.
This disease was underdiagnosed due to variable onset and clinical course.
Furthermore,
before the advent of cardiac MRI,
the diagnosis were hard because of the low spatial resolution of echocardiography compared to MRI,
and the insufficient capacity of the former to identify focal areas of hypertrophy,
particularly in the apex,
compared to the latter.
In the past,
the prognosis were considered to be more benign,
but in the last year,
several studies have suggested a higher morbidity (25-30%) and mortality (5%).
Thus,
MRI is becoming the best imaging modality for the assessment of patients with ApHCM.
The purpose of this poster is to analyze the role of cardiac MRI in the management of ApHCM and review the literature.